HY-111429-50mg
|
MedChemexpress LLC
|
YAP/TAZ inhibitor-1 [CAS 2093565-23-0]
|
|
Cancer-programmed cell death
|
|
HY-111429-1mL
|
MedChemexpress LLC
|
YAP/TAZ inhibitor-1 [CAS 2093565-23-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-19836-1mg
|
MedChemexpress LLC
|
Zimlovisertib [CAS 1817626-54-2]
|
|
COVID-19-immunoregulation
|
|
HY-19836-10mg
|
MedChemexpress LLC
|
Zimlovisertib [CAS 1817626-54-2]
|
|
COVID-19-immunoregulation
|
|
HY-19836-100mg
|
MedChemexpress LLC
|
Zimlovisertib [CAS 1817626-54-2]
|
|
COVID-19-immunoregulation
|
|
HY-19836-5mg
|
MedChemexpress LLC
|
Zimlovisertib [CAS 1817626-54-2]
|
|
COVID-19-immunoregulation
|
|
HY-19836-50mg
|
MedChemexpress LLC
|
Zimlovisertib [CAS 1817626-54-2]
|
|
COVID-19-immunoregulation
|
|
HY-19836-1mL
|
MedChemexpress LLC
|
Zimlovisertib [CAS 1817626-54-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-13343-10mg
|
MedChemexpress LLC
|
ZM 336372 [CAS 208260-29-1]
|
|
Cancer-Kinase/protease
|
|
HY-13343-5mg
|
MedChemexpress LLC
|
ZM 336372 [CAS 208260-29-1]
|
|
Cancer-Kinase/protease
|
|
HY-13343-50mg
|
MedChemexpress LLC
|
ZM 336372 [CAS 208260-29-1]
|
|
Cancer-Kinase/protease
|
|
HY-13343-1mL
|
MedChemexpress LLC
|
ZM 336372 [CAS 208260-29-1] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-155874-10mg
|
MedChemexpress LLC
|
ZNL-05-044
|
|
|
|
HY-155874-25mg
|
MedChemexpress LLC
|
ZNL-05-044
|
|
|
|
HY-155874-5mg
|
MedChemexpress LLC
|
ZNL-05-044
|
|
|
|
HY-155874-50mg
|
MedChemexpress LLC
|
ZNL-05-044
|
|
|
|
EZA001
|
Boster Biological Technology
|
EZ Set Accessory Kit [5 x 96 wells]
|
|
|
|